Dr Lal PathLabs shares plunged over 50% in early trade after the stock turned ex-bonus following a 1:1 bonus issue. The sharp fall is purely technical, reflecting price adjustment for additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback